E-LIB Suche - Ergebnisse für: Yoshizawa, Atsuhiko

1

Durable Response to Enfortumab Vedotin Compared to Re-chall..:

Uchimoto, Taizo ; Tsuchida, Shuya ; Komura, Kazumasa...
Targeted Oncology. 19 (2024) 3 - p. 401-410 , 2024

2

Prognostic Impact of Immune-Related Adverse Events as First..:

Nukaya, Takuhisa ; Takahara, Kiyoshi ; Yoshizawa, Atsuhiko...
Clinical Genitourinary Cancer. 22 (2024) 1 - p. 76-83 , 2024

Link: https://doi.org/10.1016/..

3

C-Reactive Protein-Albumin Ratio Predicts Objective Respons..:

Uchimoto, Taizo ; Matsuda, Takuya ; Komura, Kazumasa...
Targeted Oncology. , 2024

Link: https://doi.org/10.1007/..

4

Concurrent palliative radiation with pembrolizumab for plat..:

Nakamori, Keita ; Yamazaki, Shogo ; Komura, Kazumasa...
Clinical and Translational Radiation Oncology. 39 (2023) - p. 100558 , 2023

Link: https://doi.org/10.1016/..

5

Real‑world survival outcome comparing abiraterone acetate p..:

Tsujino, Takuya ; Tokushige, Satoshi ; Komura, Kazumasa...
Cancer Medicine. 12 (2023) 19 - p. 19414-19422 , 2023

Link: https://doi.org/10.1002/..

6

Alanine-Serine-Cysteine Transporter 2 Inhibition Suppresses..:

Saruta, Masanobu ; Takahara, Kiyoshi ; Yoshizawa, Atsuhiko...
Journal of Clinical Medicine. 11 (2022) 18 - p. 5466 , 2022

Link: https://doi.org/10.3390/..

7

Serum C-reactive Protein Level Predicts Overall Survival fo..:

Yano, Yusuke ; Ohno, Takaya ; Komura, Kazumasa...
Cancers. 14 (2022) 22 - p. 5659 , 2022

Link: https://doi.org/10.3390/..

8

Re‐challenging chemotherapy after pembrolizumab in platinum..:

Uchimoto, Taizo ; Fukushima, Tatsuo ; Komura, Kazumasa...
BJU International. 131 (2022) 4 - p. 477-485 , 2022

Link: https://doi.org/10.1111/..

9

Combined α-methylacyl-CoA racemase inhibition and docetaxel..:

Yoshizawa, Atsuhiko ; Takahara, Kiyoshi ; Saruta, Masanobu...
Prostate International. 9 (2021) 1 - p. 18-24 , 2021

Link: https://doi.org/10.1016/..

10

Concurrent palliative radiation with pembrolizumab for plat..:

Nakamori, Keita ; Yamazaki, Shogo ; Komura, Kazumasa...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762181/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Serum C-reactive Protein Level Predicts Overall Survival fo..:

Yano, Yusuke ; Ohno, Takaya ; Komura, Kazumasa...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688397/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Combined α-methylacyl-CoA racemase inhibition and docetaxel..:

Yoshizawa, Atsuhiko ; Takahara, Kiyoshi ; Saruta, Masanobu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053692/. , 2021

Link: http://www.ncbi.nlm.nih...

13

α-メチルアシル-CoAラセマーゼの発現抑制が去勢抵抗性前立腺癌の増殖抑制に果たす役割 ; Combined α-me..:

Yoshizawa, Atsuhiko ; 3543
Prostate Int. 2021 Mar;9(1):18-24.. , 2021

Link: https://fujita-hu.repo.n..

14

Concurrent palliative radiation with pembrolizumab for plat..:

Keita Nakamori ; Shogo Yamazaki ; Kazumasa Komura...
http://www.sciencedirect.com/science/article/pii/S2405630822001161. , 2023

Link: https://doi.org/10.1016/..

15

Real‑world survival outcome comparing abiraterone acetate p..:

Takuya Tsujino ; Satoshi Tokushige ; Kazumasa Komura...
https://doi.org/10.1002/cam4.6536. , 2023

Link: https://doi.org/10.1002/..